Gruninger Marc bought VRXA
October 27, 2026 · Form 4 insider transaction
Gruninger Marc bought 867 shares of Veraxa Biotech AG at $0.98 per share, a transaction worth $849.66. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
867
Price
$0.98
Total value
$849.66
InsiderGruninger Marc
Role—
CompanyVeraxa Biotech AG (VRXA)
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateOctober 27, 2026
Filing dateOctober 29, 2026
Shares owned after867
OwnershipDirect
10b5-1 planNo
AmendedNo